FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096551 [Registered on: 29/10/2025] Trial Registered Prospectively
Last Modified On: 27/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Compare the Effectiveness and Safety of oral syrup Melatonin versus oral syrup Triclofos Sodium for the Sedation of Children in short pediatric procedures  
Scientific Title of Study   To Compare the Effectiveness and Safety of Melatonin versus Triclofos Sodium in Procedural Sedation of Children  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ruchika Myrtle Calton  
Designation  Junior Resident  
Affiliation  Christian Medical College Ludhiana  
Address  C/O Department of Pediatrics, Christian Medical College Ludhiana, Brown Road, Ludhiana, Punjab

Ludhiana
PUNJAB
141008
India 
Phone  8427810666  
Fax    
Email  ruchicalton@yahoo.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Monika Sharma  
Designation  Professor  
Affiliation  Christian Medical College Ludhiana  
Address  C/O Department of Pediatrics, Christian Medical College Ludhiana, Brown Road, Ludhiana, Punjab, 141008
Department of Pediatrics, Christian Medical College Ludhiana, Brown Road, Ludhiana, Punjab, 141008
Ludhiana
PUNJAB
141008
India 
Phone  9814861205  
Fax    
Email  drsmonika@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ruchika Myrtle Calton  
Designation  Junior Resident  
Affiliation  Christian Medical College Ludhiana  
Address  C/O Department of Pediatrics, Christian Medical College Ludhiana, Brown Road, Ludhiana, Punjab

Ludhiana
PUNJAB
141008
India 
Phone  8427810666  
Fax    
Email  ruchicalton@yahoo.in  
 
Source of Monetary or Material Support  
nil  
 
Primary Sponsor  
Name  Dr Ruchika Myrtle Calton  
Address  C/O Department of Pediatrics, Christian Medical College Ludhiana, Brown Road, Ludhiana, Punjab, 141008 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ruchika Myrtle Calton  Christian Medical College, Ludhiana   C/O Department of Pediatrics, Christian Medical College Ludhiana, Brown Road, Ludhiana, Punjab
Ludhiana
PUNJAB 
08427810666

ruchicalton@yahoo.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Christian Medical College, Ludhiana  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  for elective procedures (BERA, EEG, CT Scan) 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Effectiveness  to compare the effectiveness of sedation provided using the RASS score 
Comparator Agent  Safety  to compare safety of sedation provided by monitoring child after administration of drug, during and after procedures 
Intervention  Sedation induced by oral medication, Melatonin and Triclofos Sodium, respectively  Randomized administration of drugs to induce sedation for elective procedures. Melatonin: Syrup Melatonin will be administered orally according to weight. 10 kg: 0.3 mg/kg, 10-15kg: 3 mg, and 15 kg: 6mg. • Maximum dose according to age: 3-6 year: 10 mg, 6 years: 20 mg. • Initial Dose to be given 30 mins prior to procedure. • Dose can be repeated if sleep not obtained within 40 mins of initial dose. Triclofos Sodium: • Syrup Triclofos will be administered orally at an initial dose of 50mg/kg. • Maximum dose according to age: 1-5 years age: 250-500mg, 6-12years: 500-1000 mg, 11-18years: till 2000 mg. • Initial Dose To be given 30mins prior to procedure. • Dose can be repeated if sleep not obtained within 40 mins of initial dose.  
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Children aged 3 to 18 years of age.
Children posted for elective procedures (BERA, EEG, and CT scan)
 
 
ExclusionCriteria 
Details  Children with Weight less than 5 Kilograms. High risk children defined by ASA-PS Score more than or equal to 3. History of adverse events during prior sedation with either of the study drugs. Invasive procedures such as biopsies and aspirations or tapping. Long procedures more than 60 mins duration. requiring long sedation. Children already on sedation for ventilation.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
compare time taken to achieve effective sedation   level of sedation monitoring to be done for each 5 minute for one hour after giving drug. 
 
Secondary Outcome  
Outcome  TimePoints 
compare the safety profile of both the drugs   vital monitoring to be done for each 5 minute for one hour after giving drug. then for each 5 minute for one hour after sedation achieved.  
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [ruchicalton@yahoo.in].

  6. For how long will this data be available start date provided 15-05-2025 and end date provided 15-10-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary   To  compare the effectiveness and safety of the drugs Melatonin and Triclofos Sodium in the procedural sedation of children. Oral form of each medications will be given to respective groups of equal number of participants and the quality and time required to achieve sedation will be recorded. also, the vital monitoring of participants will be done after giving drug, once sedation is achieved and during the procedure to assess the safety profile of the drugs.  
Close